Karl-Anthony Towns Partners with Sanofi to Promote COVID-19 Vaccination Awareness#USA#COVID-19_vaccine#Morristown#Nuvaxovid#Karl-Anthony_Towns
Karl-Anthony Towns Partners with Sanofi to Promote COVID-19 Vaccination Awareness
The 2026 NBA Champion Karl-Anthony Towns collaborates with Sanofi to promote COVID-19 vaccination awareness, focusing on NUVAXOVID, an FDA-approved vaccine.
third-news.com
October 2, 2026 at 4:09 PM
Karl-Anthony Towns Partners with Sanofi to Promote COVID-19 Vaccination Awareness#USA#COVID-19_vaccine#Morristown#Nuvaxovid#Karl-Anthony_Towns
Novavax Launches Phase 3 Trial for Combined COVID-19 and Influenza Vaccine#USA#Novavax#Gaithersburg#COVID-19_vaccine#Influenza_vaccine
Novavax Launches Phase 3 Trial for Combined COVID-19 and Influenza Vaccine
Novavax has initiated a Phase 3 trial for its COVID-19-influenza combination and stand-alone influenza vaccines, targeting older adults.
third-news.com
December 10, 2024 at 1:30 PM
Novavax Launches Phase 3 Trial for Combined COVID-19 and Influenza Vaccine#USA#Novavax#Gaithersburg#COVID-19_vaccine#Influenza_vaccine
I'm going to go dob them.on to @covid19nz and to the Vaccination Team at Health NZ
There is this fact sheet but it doesn't specifically mention Novavax
www.immune.org.nz/factsheets/c...
There is this fact sheet but it doesn't specifically mention Novavax
www.immune.org.nz/factsheets/c...
COVID-19_Vaccine booster guidance for late 2023 - Factsheets - Immunisation Advisory Centre
Those at highest risk of disease are most likely to have received their last additional dose almost 6 months ago, in April 2023. This factsheet provides guidance on who is most likely to benefit from ...
www.immune.org.nz
October 12, 2023 at 10:12 PM
I'm going to go dob them.on to @covid19nz and to the Vaccination Team at Health NZ
There is this fact sheet but it doesn't specifically mention Novavax
www.immune.org.nz/factsheets/c...
There is this fact sheet but it doesn't specifically mention Novavax
www.immune.org.nz/factsheets/c...
Walgreens Launches Updated COVID-19 Vaccines to Enhance Community Protection#United_States#COVID-19_vaccine#Flu_Vaccine#Walgreens#Deerfield
Walgreens Launches Updated COVID-19 Vaccines to Enhance Community Protection
Walgreens announces the availability of updated COVID-19 vaccines and additional vaccinations for eligible patients, ensuring community protection this fall.
third-news.com
September 4, 2026 at 1:09 PM
Walgreens Launches Updated COVID-19 Vaccines to Enhance Community Protection#United_States#COVID-19_vaccine#Flu_Vaccine#Walgreens#Deerfield
Novavax Releases Q2 2026 Financial Results with Operational Updates#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Sanofi
Novavax Releases Q2 2026 Financial Results with Operational Updates
Novavax announces its Q2 2026 financial results, showcasing significant revenue changes and updates on its vaccine programs and partnerships, particularly with Sanofi.
third-news.com
August 6, 2026 at 12:15 PM
Novavax Releases Q2 2026 Financial Results with Operational Updates#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Sanofi
Here is the official @StateHealthIN press release that announces the opening of vaccine registration to those age 65+, lest anyone think it was a mistake.
https://events.in.gov/event/hoosiers_age_65_and_older_now_eligible_for_covid-19_vaccine
https://events.in.gov/event/hoosiers_age_65_and_older_now_eligible_for_covid-19_vaccine
HOOSIERS AGE 65 AND OLDER NOW ELIGIBLE FOR COVID-19 VACCINE
INDIANAPOLIS — The Indiana Department of Health today ann...
events.in.gov
December 2, 2024 at 1:01 AM
Here is the official @StateHealthIN press release that announces the opening of vaccine registration to those age 65+, lest anyone think it was a mistake.
https://events.in.gov/event/hoosiers_age_65_and_older_now_eligible_for_covid-19_vaccine
https://events.in.gov/event/hoosiers_age_65_and_older_now_eligible_for_covid-19_vaccine
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up#Japan#Tokyo#COVID-19_vaccine#mRNA_Technology#Moderna_Japan
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up
Moderna Japan has received manufacturing and sales approval for its new COVID-19 vaccine, Emnex Spike®, for individuals aged 12 and above, enhancing immunization options.
third-news.com
May 20, 2026 at 3:02 AM
Moderna Japan Receives Approval for New COVID-19 Vaccine for Ages 12 and Up#Japan#Tokyo#COVID-19_vaccine#mRNA_Technology#Moderna_Japan
CanSinoBIO Showcases Innovations in Vaccines at World Government Summit 2026#United_Arab_Emirates#Dubai#Global_Health#COVID-19_vaccine#CanSinoBIO
CanSinoBIO Showcases Innovations in Vaccines at World Government Summit 2026
CanSino Biologics Inc. presents its groundbreaking vaccine innovations at WGS 2026, emphasizing global health accessibility and cooperation.
third-news.com
February 9, 2026 at 1:09 PM
CanSinoBIO Showcases Innovations in Vaccines at World Government Summit 2026#United_Arab_Emirates#Dubai#Global_Health#COVID-19_vaccine#CanSinoBIO
New Research Unveils Details about Gut Microbiome's Role in COVID-19 Vaccine Antibody Levels#Japan#COVID-19_vaccine#Gut_Microbiome#Kanagawa#Meiji_Holdings
New Research Unveils Details about Gut Microbiome's Role in COVID-19 Vaccine Antibody Levels
Recent research highlights a link between gut health and antibody response to the COVID-19 vaccine, revealing dietary habits that can enhance immunity.
third-news.com
November 6, 2025 at 5:27 AM
New Research Unveils Details about Gut Microbiome's Role in COVID-19 Vaccine Antibody Levels#Japan#COVID-19_vaccine#Gut_Microbiome#Kanagawa#Meiji_Holdings
SK bioscience Advances Towards First-in-Human Trial for Universal Coronavirus Vaccine in Australia#Australia#Seongnam#COVID-19_vaccine#SK_bioscience#Universal_Vaccine
SK bioscience Advances Towards First-in-Human Trial for Universal Coronavirus Vaccine in Australia
SK bioscience has filed for a Phase 1/2 trial of its universal coronavirus vaccine in Australia, aiming to combat COVID-19 and related variants with results expected by 2028.
third-news.com
October 15, 2025 at 12:19 PM
SK bioscience Advances Towards First-in-Human Trial for Universal Coronavirus Vaccine in Australia#Australia#Seongnam#COVID-19_vaccine#SK_bioscience#Universal_Vaccine
Sakura Finetech Enhances Infection Control Measures with New Vaccines#COVID-19_vaccine#Health_Initiatives#Sakura_Finetech
Sakura Finetech Enhances Infection Control Measures with New Vaccines
Sakura Finetech Japan is strengthening its infection control by offering a group vaccination program for seven diseases, including COVID-19, for its employees.
third-news.com
October 14, 2025 at 1:26 AM
Sakura Finetech Enhances Infection Control Measures with New Vaccines#COVID-19_vaccine#Health_Initiatives#Sakura_Finetech
Research Shows Osteopathic Manipulative Treatment Enhances COVID-19 Vaccine Effectiveness#USA#Pomona#COVID-19_vaccine#Western_University#Osteopathic_Manipulative_Treatment
Research Shows Osteopathic Manipulative Treatment Enhances COVID-19 Vaccine Effectiveness
A recent study reveals that Osteopathic Manipulative Treatment (OMT) can significantly enhance the immune response to COVID-19 vaccines. This research underscores the potential for OMT to improve patient outcomes during vaccination.
third-news.com
September 15, 2025 at 8:42 PM
Research Shows Osteopathic Manipulative Treatment Enhances COVID-19 Vaccine Effectiveness#USA#Pomona#COVID-19_vaccine#Western_University#Osteopathic_Manipulative_Treatment
Novavax Gains FDA Approval for Nuvaxovid™ 2025-2026 COVID-19 Vaccine#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Nuvaxovid
Novavax Gains FDA Approval for Nuvaxovid™ 2025-2026 COVID-19 Vaccine
Novavax's Nuvaxovid™ vaccine has received FDA approval, marking a significant advancement in COVID-19 prevention for at-risk populations. Learning more about its impact.
third-news.com
August 27, 2025 at 7:14 PM
Novavax Gains FDA Approval for Nuvaxovid™ 2025-2026 COVID-19 Vaccine#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Nuvaxovid
Novavax Unveils Positive Results for Combined COVID-19 and Influenza Vaccine in Phase 3 Trial#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Influenza_vaccine
Novavax Unveils Positive Results for Combined COVID-19 and Influenza Vaccine in Phase 3 Trial
Novavax has reported promising initial results for its combined COVID-19-Influenza vaccine and a stand-alone flu vaccine. Both candidates showed strong immune responses in a Phase 3 trial.
third-news.com
June 11, 2025 at 11:16 AM
Novavax Unveils Positive Results for Combined COVID-19 and Influenza Vaccine in Phase 3 Trial#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Influenza_vaccine
Dx&Vx Accelerates Universal COVID-19 Vaccine Development Amid Global Resurgence#South_Korea#Seoul#COVID-19_vaccine#Dx&Vx#Universal_Treatment
Dx&Vx Accelerates Universal COVID-19 Vaccine Development Amid Global Resurgence
Bio-healthcare firm Dx&Vx is speeding up its universal COVID-19 vaccine after acquiring advanced technology, essential amid a new wave of infections.
third-news.com
May 29, 2025 at 1:20 PM
Dx&Vx Accelerates Universal COVID-19 Vaccine Development Amid Global Resurgence#South_Korea#Seoul#COVID-19_vaccine#Dx&Vx#Universal_Treatment
FDA Grants Approval for Novavax's COVID-19 Vaccine, Nuvaxovid™, Targeting High-Risk Groups#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Nuvaxovid
FDA Grants Approval for Novavax's COVID-19 Vaccine, Nuvaxovid™, Targeting High-Risk Groups
The FDA has approved Novavax's Nuvaxovid™, a protein-based COVID-19 vaccine, aimed at high-risk adults 65 and older and those aged 12 to 64 with underlying conditions.
third-news.com
May 19, 2025 at 11:24 AM
FDA Grants Approval for Novavax's COVID-19 Vaccine, Nuvaxovid™, Targeting High-Risk Groups#United_States#Novavax#Gaithersburg#COVID-19_vaccine#Nuvaxovid
Novavax's Vaccine Research Reveals Fewer Side Effects Compared to mRNA Alternatives#United_States#Utah#Novavax#COVID-19_vaccine#mRNA
Novavax's Vaccine Research Reveals Fewer Side Effects Compared to mRNA Alternatives
The SHIELD-Utah study showcases Novavax's COVID-19 vaccine producing fewer and milder side effects than the Pfizer-BioNTech mRNA version, impacting daily life less.
third-news.com
April 15, 2025 at 11:19 AM
Novavax's Vaccine Research Reveals Fewer Side Effects Compared to mRNA Alternatives#United_States#Utah#Novavax#COVID-19_vaccine#mRNA
Essential Health and Safety Tips for a Joyful Holiday Season#United_States#Mission#COVID-19_vaccine#Flu_Vaccine#RSV_Awareness
Essential Health and Safety Tips for a Joyful Holiday Season
As the holiday season approaches, prioritize your health and safety with crucial vaccination tips to enjoy festive gatherings without worry.
third-news.com
December 16, 2024 at 9:05 PM
Essential Health and Safety Tips for a Joyful Holiday Season#United_States#Mission#COVID-19_vaccine#Flu_Vaccine#RSV_Awareness
403 Forbidden
www.bellcountyhealth.org
November 18, 2024 at 7:38 PM